Table 4 Serum levels of VEGF, PD-ECGF/TP activity and leptin in patients groups in relation to age, weight, hemoglobin and SpO2 levels.
From: Angiogenic biomarkers in children with congenital heart disease: possible implications
Biomarkers | VEGF (pg/ml) | PD-ECGF (U/ml) | Leptin (ng/ml) | |||||
|---|---|---|---|---|---|---|---|---|
Patients groups | Â | C-CHD (n = 30) | A-CHD (n = 30) | C-CHD (n = 30) | A-CHD (n = 30) | C-CHD (n = 30) | A-CHD (n = 30) | |
|  | <3 ys (n = 39) | 265 ± 100 | 296 ± 79 | 29 ± 7 | 20 ± 10.2 | 39 ± 12 | 32 ± 10 | |
Age (years) | Â | Â | Â | Â | Â | Â | Â | Â |
|  | >3 ys (n = 21) | 574 ± 92* | 310 ± 91§ | 34 ± 9.3§ | 27 ± 6§ | 43 ± 6.5§ | 33.6 ± 5.9§ | |
|  | <10 Kg (n = 34) | 400 ± 96 | 306 ± 74 | 28.6 ± 7.8 | 25 ± 4.9 | 22 ± 4.9 | 20.9 ± 8.9 | |
Weight (Kg) | Â | Â | Â | Â | Â | Â | Â | Â |
|  | >10 Kg (n = 26) | 413 ± 78§ | 327 ± 36§ | 33 ± 6.4§ | 30 ± 6.7§ | 43 ± 10†| 45.3 ± 9†| |
|  | <10 gm/dl (n = 32) | 275 ± 102 | 300.5 ± 90 | 18.4 ± 6.4 | 21.2 ± 7.3 | 41 ± 7.9 | 31 ± 4.8 | |
Hemoglobin (g./dl) | Â | Â | Â | Â | Â | Â | Â | Â |
|  | >10 gm/dl (n = 28) | 567 ± 95* | 313.2 ± 76§ | 39 ± 9.6†| 24.9 ± 6§ | 43.8 ± 8§ | 33.7 ± 5.6§ | |
|  | <90% (n = 35) | 582 ± 98 | 408 ± 59.2 | 48.3 ± 7.8 | 33 ± 5.4 | 49 ± 12 | 46.8 ± 9.5 | |
SpO2 (%) | Â | Â | Â | Â | Â | Â | Â | Â |
|  | >90% (n = 25) | 206 ± 39* | 210 ± 65.4* | 27 ± 9.6†| 18 ± 6.9†| 27.8 ± 10.8‡ | 22 ± 6.2 ‡ | |